ENDRA Life Sciences Inc. (NDRA)

USD 4.62

(0.87%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - 6174.00
Cost of Revenue 275.45 Thousand 234.25 Thousand 224.41 Thousand 165.24 Thousand 115.01 Thousand -
Gross Profit -275.45 Thousand -234.25 Thousand -224.41 Thousand -165.24 Thousand -115.01 Thousand 6174.00
Operating Expenses 10.52 Million 13.15 Million 11.49 Million 11.5 Million 10.84 Million 8.73 Million
Selling, General and Administrative Expenses 5.51 Million 6.6 Million 6.01 Million 5.58 Million 4.26 Million 4.01 Million
Research and Development Expenses 5 Million 6.55 Million 5.48 Million 5.91 Million 6.57 Million 4.72 Million
Other Expenses - -21.53 Thousand -41.54 Thousand 8842.00 -106.9 Thousand -777.25 Thousand
Cost and Expenses 10.52 Million 13.15 Million 11.49 Million 11.5 Million 10.84 Million 8.73 Million
Operating Income -10.52 Million -13.15 Million -11.49 Million -11.5 Million -10.84 Million -9.01 Million
Interest Expense - 21.53 Thousand - 232.42 Thousand 2.35 Million -
Income Tax Expense - 21.53 Thousand -41.54 Thousand 241.26 Thousand 2.24 Million -777.25 Thousand
Earnings before Tax -10.06 Million -13.17 Million -11.23 Million -11.72 Million -13.3 Million -9.79 Million
Net Income -10.06 Million -13.2 Million -11.18 Million -11.96 Million -15.55 Million -9.79 Million
Earnings Per Share Basic -1.11 -4.57 -5.47 -12.47 -41.48 -43.49
Earnings Per Share Diluted -1.11 -4.57 -5.47 -12.47 -41.48 -43.49
Weighted Average Shares Outstanding 9.03 Million 2.89 Million 2.04 Million 959.61 Thousand 374.99 Thousand 225.24 Thousand
Weighted Average Shares Outstanding (Diluted) 9.03 Million 2.89 Million 2.04 Million 959.61 Thousand 374.99 Thousand 225.24 Thousand
Gross Margin - - - - - 1.00
EBIT Margin - - - - - -1356.59
Profit Margin - - - - - -1586.70
EBITDA -9.78 Million -12.94 Million -11 Million -11.32 Million -10.83 Million -9.01 Million
Earnings Before Tax Margin - - - - - -1460.80

Income Statement Charts